Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium.

Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium.

Item
http://www.wikidata.org/entity/Q41640883
Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder.Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis.Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.50 Years with lithium treatment in affective disorders: present problems and priorities.Clinical use of carbamazepine for bipolar disorders.A review of the evidence for the use of antipsychotics in the maintenance treatment of bipolar disorders.A randomized open comparison of long-acting injectable risperidone and treatment as usual for prevention of relapse, rehospitalization, and urgent care referral in community-treated patients with rapid cycling bipolar disorder.Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder.Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder.Long-Acting Injectable Antipsychotics for Prevention of Relapse in Bipolar Disorder: A Systematic Review and Meta-Analyses of Randomized Controlled Trials.Syringe driver in terminal care.The use of atypical antipsychotics in Bipolar Spectrum disorders.Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders.Should the term 'antipsychotic' be changed to 'multidimensional stabiliser' in bipolar disorder? Towards a new denomination for 'atypical antipsychotics'.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.Rethinking the spectrum of mood disorders: implications for diagnosis and management – Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, France.
P2860

Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium.

Item
http://www.wikidata.org/entity/Q41640883
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium.
@en
type
label
Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium.
@en
prefLabel
Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1600-0447.1981.TB00778.X
P407
P433
P478
P50
P577
P698